Primary Medical Therapy for Breast Cancer: Clinical and Biological Aspects (European School of Oncology Scientific Updates, 4)

Summarizes the current status of primary medical therapy, and discusses new approaches which are required to progress this approach in breast cancer patients. The nine papers review the results of trials of primary chemotherapy (PCT) and primary endocrine therapy (PET) together with clinical-laboratory studies aimed at improving treatment choices and predicting long-term outcome. Topics include biological markers and changes induced in their profiles following primary chemotherapy, and TP53 as a predictor of response to chemotherapy in breast cancer. Annotation c. Book News, Inc., Portland, OR (booknews.com)